BRIEF-Mimedx urges FDA to reconsider draft guidances
 

BRIEF-Mimedx urges FDA to reconsider draft guidances
* Mimedx says continues to believe that its marketing ofits products as section 361 hct/ps is consistent with applicablestatutes and regulationshttp://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...T0:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...T0:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/eE_brhc_nwk